Health
Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro – News-Medical.Net
In a study published on the bioRxiv preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of the antihistamine azelastine to inhibit SARS-CoV-2 infection in human nasal tissue in vitro.
In a study published on the bioRxiv* preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of the antihistamine azelastine to inhibit SARS-CoV-2 infection in human nasal tissue in vitro.
The COVID-19 pandemic has caused a pressing need for the rapid development of both preventive and therapeutic approaches to fight the virus. Given the urgency, going through the traditional drug discovery and development pathway is not feasible…
-
Noosa News22 hours agoQueensland teachers strike for second time this year after rejecting 8 per cent wage rise
-
General22 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Noosa News13 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General24 hours agoTrump, Xi talk on phone about trade, Taiwan and Ukraine